Specify a stock or a cryptocurrency in the search bar to get a summary
Celon Pharma SA
CLNCelon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o. Address: Ogrodowa 2A, Lomianki, Poland, 05-092
Analytics
WallStreet Target Price
94.34 PLNP/E ratio
–Dividend Yield
0.32 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CLN
Dividend Analytics CLN
Dividend growth over 5 years
-47 %Continuous growth
–Payout Ratio 5 years average
5 %Dividend History CLN
Stock Valuation CLN
Financials CLN
Results | 2019 | Dynamics |